Opportunities in platform technologies

Opportunities in platform technologies

Antibody Facility: Victorian Antibody Initiative

The Victorian Antibody Initiative brings together:

  • Premier customised development services at the institute
  • State-of-the-art automated high-throughput monoclonal antibody production facilities at the Monash University
  • Large-scale protein production and processing capabilities at CSIRO’s Recombinant Protein Production Facility

For more information, download the printable flyer.

Monoclonal and polyclonal antibody out-licensing

Our researchers have generated numerous monoclonal and polyclonal antibodies that are available for licensing.

Categories include:

  • Apoptosis
  • Cancer
  • Cell surface proteins
  • Immunology
  • Intracellular proteins
  • Malaria
  • Necroptosis
  • Transcription factors

 

To discuss partnering opportunities, please contact Technology Development Associate Dr David Segal by email segal@wehi.edu.au or phone +61 3 9345 2418.